Venneti, S, Kawakibi, AR, Ji, S, Waszak, SM, Sweha, SR, Mota, M, Pun, M, Deogharkar, A, Chung, C, Tarapore, RS, Ramage, S, Chi, A, Wen, PY, Arrillaga-Romany, I, Batchelor, TT, Butowski, NA, Sumrall, A, Shonka, N, Harrison, RA, Groot, JD, Mehta, M, Hall, MD, Daghistani, D, Cloughesy, TF, Ellingson, BM, Beccaria, K, Varlet, P, Kim, MM, Umemura, Y, Garton, H, Franson, A, Schwartz, J, Jain, R, Kachman, M, Baum, H, Burant, CF, Mottl, SL, Cartaxo, RT, John, V, Messinger, D, Qin, T, Peterson, E, Sajjakulnukit, P, Ravi, K, Waugh, A, Walling, D, Ding, Y, Xia, Z, Schwendeman, A, Hawes, D, Yang, F, Judkins, AR, Wahl, D, Lyssiotis, CA, Nava, DDL, Alonso, MM, Eze, A, Spitzer, J, Schmidt, SV, Duchatel, RJ, Dun, MD, Cain, JE, Jiang, L, Stopka, SA, Baquer, G, Regan, MS, Filbin, MG, Agar, NYR
, Zhao, L, Kumar-Sinha, C, Mody, R, Chinnaiyan, A, Kurokawa, R, Pratt, D, Yadav, VN, Grill, J, Kline, C, Mueller, S, Resnick, A, Nazarian, J, Allen, JE, Odia, Y, Gardner, SL & Koschmann, C 2025, '
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways',
Cancer discovery, vol. 15, no. 3, pp. 657.
https://doi.org/10.1158/2159-8290.CD-25-0208